Empowering patient care: in-process and quality control solutions for cellular therapies

The successful clinical implementation of cell and gene therapy (CGT) requires dependable point-of-care approaches, to ensure the delivery of high-quality cell products to patients in need. Standardized in-process and quality controls (IPC/QC) that enable compliance with regulatory guidelines are therefore critical for reliable assessment of the safety and efficacy of cellular therapies throughout cell manufacturing workflows.

Join us to learn more about how to optimize point-of-care practices, focusing on analytical development and release testing. Learn about the importance of easy-to-implement strategies to streamline IPC/QC methodologies and take the opportunity to get expert insights on the latest advancements in CGT.

Don’t miss the chance to:

• Understand the possibilities and challenges of point-of-care practices in CGT
• Dive into innovative flow cytometry-based workflows used for the analysis of critical quality attributes in cell manufacturing
• Discover effective strategies to streamline IPC/QC methodologies and their impact on CGT
• Learn from successful stories in point-of-care

Christin Tischner

Senior Project Manager, Global Point of Care Strategy at Miltenyi Biotec

Dr. Christin Tischner works at Miltenyi Biotec as senior project manager of global point-of-care (PoC) strategy. Dr. Tischner has extensive expertise on CAR T cell manufacturing and workflow planning for clinical studies.

Simon Lennartz

Doctoral Candidate at Universitätsklinikum Köln

Simon Lennartz is currently working on his PhD thesis at the Uniklinik Köln, where he oversees the development of new CAR and TCR strategies to improve adoptive T cell therapy.

in 24

Days

Register

SPEAKERS

Christin Tischner

Senior Project Manager, Global Point of Care Strategy at Miltenyi Biotec

Simon Lennartz

Doctoral Candidate at Universitätsklinikum Köln

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual

27 June

in 59

Days

Register

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko

6 June

in 38

Days

Register

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Y Brudno, O Veiseh, M Delic-Schlumbohm et al.

5 June

in 37

Days

Register

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe

29 May

in 30

Days

Register

It’s a match: cell line engineering for AAV manufacturing expands the options for therapeutic programs

Dovilé Woods

28 May

in 29

Days

Register